Paradigm Health Acquires Flatiron Health's Clinical Research Business
December 4, 2025
Paradigm Health has acquired Flatiron Health’s Clinical Research Business and entered a multi-year strategic partnership to integrate Flatiron’s research network and solutions with Paradigm’s AI-powered trial platform. The deal expands Paradigm’s oncology research network to include more academic medical centers and nearly 100 community oncology practices, increasing access to clinical trials across the United States; terms were not disclosed.
- Buyers
- Paradigm Health, Inc.
- Targets
- Flatiron Health's Clinical Research Business
- Sellers
- Flatiron Health
- Industry
- Healthcare Services
- Location
- New York, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Flatiron Health Acquires Protocol First
December 16, 2021
Cloud & SaaS
Flatiron Health has acquired Protocol First, a Salt Lake City–based provider of clinical research software, making Protocol First a wholly owned subsidiary effective Dec. 14. The acquisition integrates Protocol First's EHR-to-EDC connector and research workflow tools into Flatiron's Clinical Research business unit to expand Flatiron's real-world evidence and clinical research capabilities.
-
Adams Clinical Acquires InSite Clinical Research
December 11, 2024
Healthcare Services
Adams Clinical has agreed to acquire InSite Clinical Research, a Dallas–Fort Worth clinical trial site specializing in inpatient and outpatient psychiatric and neurologic trials, expanding Adams' capabilities into inpatient psychiatry and Schizophrenia trials. The deal adds a Texas footprint for Adams and follows Adams' broader 2024 expansion; InTandem Capital Partners (Adams' investor) commented on the partnership.
-
SAI MedPartners Acquires Fulcrum Research Group
January 4, 2023
Healthcare Services
SAI MedPartners, a consultancy backed by Northlane Capital Partners, has acquired Fulcrum Research Group, a Waltham, MA-based primary market research firm focused on healthcare and biopharma. The add-on expands SAI's strategic insights and primary research capabilities to better serve pharmaceutical, biotechnology, and medical device clients.
-
InTandem Capital Partners Makes Growth Investment in Adams Clinical
May 21, 2024
Healthcare Services
InTandem Capital Partners, a healthcare-focused private equity firm, has partnered with the founders and management team of Adams Clinical, a Watertown, Massachusetts–based clinical trial site network focused on psychiatric and neurologic indications. The investment will support Adams Clinical’s growth and development of its site network and patient recruitment capabilities to better serve pharmaceutical sponsors and CROs.
-
Paradigm Acquires HomeCare Connect
December 8, 2021
Healthcare Services
Paradigm, an accountable specialty care management organization, has acquired HomeCare Connect, a specialty network focused on home health, durable medical equipment (DME), and related post-acute services. The acquisition expands Paradigm's clinical solution set and extends its accountable care management model into the home to better serve catastrophic and complex cases.
-
Elligo Health Research Acquires ClinEdge in $135M Transaction
September 23, 2021
Healthcare Services
Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.